CASCADE INVESTMENT, L.L.C. - 16 Sep 2021 Form 3 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Role
10%+ Owner
Signature
Cascade Investment, L.L.C. By: /s/ Alan Heuberger, Attorney-in-fact for Michael Larson, Business Manager
Issuer symbol
DNA
Transactions as of
16 Sep 2021
Net transactions value
$0
Form type
3
Filing time
24 Sep 2021, 16:24:22 UTC
Previous filing
06 Aug 2021
Next filing
28 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DNA Class A Common Stock 151,865,481 16 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 15,949,483 earn-out shares that will vest in four substantially equal installments if the issuer's Class A Common Stock achieves a price per share for any period of 20 trading days out of 30 consecutive trading days prior to September 16, 2026 that equals or exceeds the following thresholds: $12.50, $15.00, $17.50 and $20.00.

Remarks:

Exhibit List: Exhibit 24.1 - Power of Attorney (Cascade Investment, L.L.C.); Exhibit 24.2 - Power of Attorney (William H. Gates III)